Clinical Trial Update: Effect of Hydralazine on Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the effect of hydralazine on Alzheimer's disease is currently in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Hydralazine (hydralazine)

Snippet

Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services | Conditions: Alzheimer Disease | Phase 3 | Status: UNKNOWN